Nasal IL-5 levels determine the response to anti-IL-5 treatment in patients with nasal polyps.

[1]  T. Haverty,et al.  Safety and efficacy of the monoclonal anti-interleukin-5 antibody SCH55700 in the treatment of patients with hypereosinophilic syndrome. , 2004, Blood.

[2]  J. Ring,et al.  Use of an anti-interleukin-5 antibody in the hypereosinophilic syndrome with eosinophilic dermatitis. , 2003, The New England journal of medicine.

[3]  S. Phipps,et al.  Anti-IL-5 treatment reduces deposition of ECM proteins in the bronchial subepithelial basement membrane of mild atopic asthmatics. , 2003, The Journal of clinical investigation.

[4]  D. Postma,et al.  Effect of SCH55700, a humanized anti-human interleukin-5 antibody, in severe persistent asthma: a pilot study. , 2003, American journal of respiratory and critical care medicine.

[5]  S. Phipps,et al.  Differential Regulation of Human Eosinophil IL-3, IL-5, and GM-CSF Receptor α-Chain Expression by Cytokines: IL-3, IL-5, and GM-CSF Down-Regulate IL-5 Receptor α Expression with Loss of IL-5 Responsiveness, but Up-Regulate IL-3 Receptor α Expression 1 , 2003, The Journal of Immunology.

[6]  C. Bachert,et al.  Enhanced soluble interleukin‐5 receptor alpha expression in nasal polyposis , 2003, Allergy.

[7]  A. Kay,et al.  Eosinophil's role remains uncertain as anti-interleukin-5 only partially depletes numbers in asthmatic airway. , 2003, American journal of respiratory and critical care medicine.

[8]  Lin Ying Liu,et al.  Decreased Expression of Membrane IL-5 Receptor α on Human Eosinophils: I. Loss of Membrane IL-5 Receptor α on Airway Eosinophils and Increased Soluble IL-5 Receptor α in the Airway After Allergen Challenge1 , 2002, The Journal of Immunology.

[9]  Lin Ying Liu,et al.  Decreased Expression of Membrane IL-5 Receptor α on Human Eosinophils: II. IL-5 Down-Modulates Its Receptor Via a Proteinase-Mediated Process1 , 2002, The Journal of Immunology.

[10]  Rakesh K. Kumar,et al.  Interleukin-5 and eosinophils as therapeutic targets for asthma. , 2002, Trends in molecular medicine.

[11]  R. Pauwels,et al.  The Allergen-Induced Airway Hyperresponsiveness in a Human-Mouse Chimera Model of Asthma Is T Cell and IL-4 and IL-5 Dependent , 2001, The Journal of Immunology.

[12]  R. Egan,et al.  Th2 cytokines and asthma — The role of interleukin-5 in allergic eosinophilic disease , 2001, Respiratory research.

[13]  J. Denburg,et al.  Regulation of IL-5 Receptor on Eosinophil Progenitors in Allergic Inflammation: Role of Retinoic Acid , 2001, International Archives of Allergy and Immunology.

[14]  K. Chung,et al.  Effects of an interleukin-5 blocking monoclonal antibody on eosinophils, airway hyper-responsìveness, and the late asthmatic response , 2000, The Lancet.

[15]  C. Bachert,et al.  Nasal Polyposis: From Cytokines to Growth , 2000, American journal of rhinology.

[16]  P. Foster,et al.  The Effect of IL-5 and Eotaxin Expression in the Lung on Eosinophil Trafficking and Degranulation and the Induction of Bronchial Hyperreactivity1 , 2000, The Journal of Immunology.

[17]  Pauwels,et al.  Airway eosinophilia is not a requirement for allergen‐induced airway hyperresponsiveness , 2000, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.

[18]  C. Bachert,et al.  IL-5 synthesis is upregulated in human nasal polyp tissue. , 1997, The Journal of allergy and clinical immunology.

[19]  C. Bachert,et al.  Direct demonstration of delayed eosinophil apoptosis as a mechanism causing tissue eosinophilia. , 1997, Journal of immunology.

[20]  P. Foster,et al.  Interleukin 5 deficiency abolishes eosinophilia, airways hyperreactivity, and lung damage in a mouse asthma model , 1996, The Journal of experimental medicine.

[21]  J. Tavernier,et al.  Identification of receptor-binding domains on human interleukin 5 and design of an interleukin 5-derived receptor antagonist. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[22]  J. Tavernier,et al.  Organization and chromosomal localization of the human interleukin 5 receptor alpha-chain gene. , 1992, European cytokine network.

[23]  J. Tavernier,et al.  Molecular basis of the membrane-anchored and two soluble isoforms of the human interleukin 5 receptor alpha subunit. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[24]  C. Sanderson.  Interleukin-5, Eosinophils, and Disease , 1992 .

[25]  M. Migita,et al.  Molecular cloning and expression of the human interleukin 5 receptor , 1992, The Journal of experimental medicine.

[26]  G. Settipane,et al.  Nasal polyps in asthma and rhinitis. A review of 6,037 patients. , 1977, The Journal of allergy and clinical immunology.